Abstract
Poor water solubility and rapid degradation of curcumin limit its tissue absorption in vivo and significantly impair its therapeutic efficacy. To enhance the aqueous solubility and improve the bioavailability of curcumin, supercritical CO2 antisolvent carbonization technology was used to prepare CUR/CaCO3 and PVP/CUR/CaCO3 composite particles. The optimal preparation process for CUR/CaCO3 composite particles were screened through a single-factor experimental method. The effects of PVP concentration on particle morphology, size, drug loading capacity, and dissolution performance were investigated to optimize the preparation conditions of PVP/CUR/CaCO3 composite particles. The physicochemical properties of the composite particles were characterized by EDS, XRD, FT-IR, TG-DSC, UV-Vis, LC-MS, and ¹H NMR. The results indicated that curcumin was loaded within the calcium carbonate in an amorphous or microcrystalline state. In vitro drug release studies demonstrated that the CUR/CaCO3 composite particles exhibited improved dissolution behavior and the dissolution capacity of PVP/CUR/CaCO3 composite particles has been significantly enhanced compared to both CUR/PVP solid dispersions and physical mixtures across various buffers. In vitro bioactivity experiments showed that the PVP/CUR/CaCO3 composite particles exhibited excellent DPPH radical scavenging activity, inhibitory effects against Staphylococcus aureus, and cytotoxicity toward A549 lung cancer cells.